» Articles » PMID: 9371503

Induction of Activating Transcription Factor 1 by Nickel and Its Role As a Negative Regulator of Thrombospondin I Gene Expression

Overview
Journal Cancer Res
Specialty Oncology
Date 1997 Nov 26
PMID 9371503
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Thrombospondin I (TSP I) is an extracellular matrix glycoprotein that influences cell adhesion, motility, and growth. On the basis of its effects on endothelial cell proliferation, TSP I has attracted interest as a potential regulator of solid tumor growth through modulation of tumor blood supply. The regulation of TSP I expression is of critical importance for designing new approaches in tumor therapy. Recently, we have shown that TSP I expression is lost in nickel-transformed cells. In this paper, we identified an activating transcription factor (ATF)/cAMP-responsive element-binding protein binding site as a negative regulatory site in the 5'-flanking sequence of mouse TSP I promoter. We identified ATF-1 as a major component of the ATF/cAMP-responsive element-binding protein binding complex. This Mr 35,000 nuclear ATF-1 protein was shown to be present in higher amounts in nickel-transformed 3T3 cells that do not express TSP 1. Acute treatment of 3T3 cells with NiCl2 resulted in the induction of this transcription factor, and this induction was correlated temporally with the suppression of TSP I expression in the same cells. These results show that nickel exposure causes accumulation of the ATF-1 transcription factor, which is responsible for the down-regulation of transcription of TSP I, and possibly other tumor suppressor genes during nickel-induced cellular transformation.

Citing Articles

Phosphorylated ATF1 at Thr184 promotes metastasis and regulates MMP2 expression in gastric cancer.

Li T, Cao H, Wu S, Zhong P, Ding J, Wang J J Transl Med. 2022; 20(1):169.

PMID: 35397606 PMC: 8994398. DOI: 10.1186/s12967-022-03361-3.


Down-regulation of ATF1 leads to early neuroectoderm differentiation of human embryonic stem cells by increasing the expression level of SOX2.

Yang S, Liu J, Wang C, Lin Y, Tsai S, Chen W FASEB J. 2019; 33(9):10577-10592.

PMID: 31242772 PMC: 6704446. DOI: 10.1096/fj.201800220RR.


Targeting Overexpressed Activating Transcription Factor 1 (ATF1) Inhibits Proliferation and Migration and Enhances Sensitivity to Paclitaxel In Esophageal Cancer Cells.

Hao Q, Zhao X, Zhang Y, Dong Z, Hu T, Chen P Med Sci Monit Basic Res. 2017; 23:304-312.

PMID: 28912415 PMC: 5612263. DOI: 10.12659/MSMBR.906289.


Decreased astrocytic thrombospondin-1 secretion after chronic ammonia treatment reduces the level of synaptic proteins: in vitro and in vivo studies.

Jayakumar A, Tong X, Curtis K, Ruiz-Cordero R, Shamaladevi N, Abuzamel M J Neurochem. 2014; 131(3):333-47.

PMID: 25040426 PMC: 4364553. DOI: 10.1111/jnc.12810.


Invoking the power of thrombospondins: regulation of thrombospondins expression.

Stenina-Adognravi O Matrix Biol. 2014; 37:69-82.

PMID: 24582666 PMC: 4143502. DOI: 10.1016/j.matbio.2014.02.001.